Key facts
- It has raised $13.7M; the latest was Early Stage VC ($13.7M) in Jan 2025.
- Notable investors include Zhuhai High-tech Financial Investment, Cenova Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Haofeng Medtech
- ·The full record, as it builds
Funding rounds
No funding rounds for Haofeng Medtech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Haofeng Medtech
Developers of interventional medical devices. The company focuses on interventional medical device's contract, development, manufacturing and organization (CDMO) services. According to the service needs of the CDMO industry chain, the company has set up different wholly-owned subsidiaries to meet customer needs, enabling clients to improve treatment efficiency.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2013
- Website
- hfmedtech.com/
- Ownership
- Privately Held (backing)
Haofeng Medtech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Haofeng Medtech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Haofeng Medtech in its N-PORT filings yet. We sweep new filings monthly.